| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |